［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］王慧,李梦妍,袁媛,等.172例新疆哈萨克族食管鳞状细胞癌临床病理资料分析［J］.现代肿瘤医学,2016,24(4):562-565.
WANG H,LI MY,YUAN Y,et al.Clinical pathological data analysis of 172 cases of esophageal squamous cell carcinoma of Kazakhs in Xinjiang［J］.Modern Oncology,2016,24(4):562-565.
［3］SHORT MW,BURGERS KG,FRY VT.Esophageal cancer［J］.Am Fam Physician,2017,95(1):22-28.
［4］JOSEPH LN.Cellular retinoid binding-proteins,CRBP,CRABP,FABP5:effects on retinoid metabolism,function and related diseases［J］.Pharmacol Ther,2017,173(5):19-33.
［5］李超,李梦妍,马遇庆.基于GEO数据库分析CRABP2在食管鳞癌中的表达及作用［J］.新疆医科大学学报,2022,45(7):703-709.
LI C,LI MY,MA YQ.Expression and function analysis of CRABP2 and FABP5,and their ratio in esophageal squamous cell carcinoma［J］.Journal of Xinjiang Medical University,2022,45(7):703-709.
［6］YANG QY,WANG R,XIAO WF,et al.Cellular retinoic acid binding protein 2 is strikingly downregulated in human esophageal squamous cell carcinoma and functions as a tumor suppressor［J］.Plos One,2016,11(2):e0148381.
［7］ZHANG CY,LIAO YD,LIU P,et al.FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism［J］.Theranostics,2020,10(15):6561-6580.
［8］KUMAR A,KAUR J,CHATTOPADHYAY TK,et al.Differential expression of retinoic acid receptors in normal and malignant esophageal tissues［J］.Journal of Experimental Therapeutics and Oncology,2004,1(4):1-8.
［9］FISCHER S,DOMBROWSKI A,HAGEL C,et al.The cellular retinoic acid binding protein 2 promotes survival of malignant peripheral nerve sheath tumor cells［J］.Am J Pathol,2017,187(7):1623-1632.
［10］SEIDENSAAL K,NOLLERT A,FEIGE AH,et al.Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma［J］.Mol Cancer,2015,3(14):204-226.
［11］AI-JAMEEL W,GOU XJ,JIN X,et al.Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ［J］.Genes & Cancer,2019,10(4):80-96.
［12］WU GZ,XU YK,WANG QF,et al.FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma［J］.European Journal of Pharmacology,2019,5(862):172637.
［13］PETRIE K,URBAN-WOJCIUK Z,SBIRKOV Y,et al.Retinoic acid receptor gamma is a therapeutically targetable driver of growth and survival in prostate cancer［J］.Cancer Reports,2020,3(6):e1284.
［14］HUGHES CS,CHINALEONG JA,KOCHER HM.CRABP2 and FABP5 expression levels in diseased and normal pancreas［J］.Ann Diagn Pathol,2020,8(47):151557.
［15］白刚,罗林,王行桥,等.CRABP-Ⅱ、FABP-5在颅咽管瘤中的表达［J］.昆明医科大学学报,2013,6(34):75-78.
BAI G,LUO L,WANG XQ,et al.Expression of CRABP-Ⅱand FABP-5 in craniopharyngioma［J］.Journal of Kunming Medical University,2013,6(34):75-78.
［16］XIA SL,WU ML,LI H,et al.CRABP-II and FABP5 independent responsiveness of human glioblastoma cells to all-trans retinoic acid［J］.Oncotarget,2015,6(8):5889-5902.
［17］JU J,WANG N,WANG J,et al.4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation,invasion,and migration of breast cancer cells by independently regulating CRABP2 and FABP5［J］.Drug Design Dev Ther,2018,4(12):997-1008.
［18］CHAMILA K,SWATI C,QING X,et al.Role of retinoic acid receptor-g in DNA damage induced necroptosis［J］.iScience,2019,7(17):74-86.
［19］GAN WJ,WANG JR,ZHU XL,et al.RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis［J］.Journal of Experimental & Clinical Cancer Research,2016,35(1):164-182.
［20］WANG X,WANG G,SHI Y,et al.PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions［J］.Oncogenesis,2016,5(6):232-251.
［21］NATALIA MM,AMAIA ZL,SONIA FR,et al.PPARδ elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth［J］.Cancer Res,2018,78(2):399-409.